Literature DB >> 7361749

Illness after influenza vaccination reported through a nationwide surveillance system, 1976-1977.

H F Retailliau, A C Curtis, G Storr, G Caesar, D L Eddins, M A Hattwick.   

Abstract

In 1976, the Center for Disease Control coordinated nationwide surveillance for illnesses after influenza vaccination as part of an effort to vaccinate the nation against influenza A/New Jersey/76. For the 48,161,019 persons vaccinated in 1976, a total of 4733 reports of illness were received which included reports of 223 deaths. When Guillain-Barré syndrome was reported in vaccine recipients, an investigation was begun to examine this possible association. Other than the Guillain-Barré syndrome and rare cases of anaphylaxis, no serious illnesses were causally associated with influenza vaccination by this type of surveillance. Widespread underreporting of illness and death in the passive phase of this surveillance system, however, impaired the ability to draw conclusions about reactions to vaccine from the reports of illness received.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7361749     DOI: 10.1093/oxfordjournals.aje.a112896

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.

Authors:  Lisa A Prosser; Megan A O'Brien; Noelle-Angelique M Molinari; Katherine H Hohman; Kristin L Nichol; Mark L Messonnier; Tracy A Lieu
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  Unreviewed reports.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-03

3.  Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Authors:  Sharon K Greene; Melisa Rett; Eric S Weintraub; Lingling Li; Ruihua Yin; Anthony A Amato; Doreen T Ho; Sarah I Sheikh; Bruce H Fireman; Matthew F Daley; Edward A Belongia; Steven J Jacobsen; Roger Baxter; Tracy A Lieu; Martin Kulldorff; Claudia Vellozzi; Grace M Lee
Journal:  Am J Epidemiol       Date:  2012-05-11       Impact factor: 4.897

4.  Administration of the adjuvanted pH1N1 vaccine in egg-allergic children at high risk for influenza A/H1N1 disease.

Authors:  Jane E Schuler; W James King; Natalie L Dayneka; Lynn Rastelli; Evelyn Marquis; Zave Chad; Charles Hui
Journal:  Can J Public Health       Date:  2011 May-Jun

Review 5.  Current understanding of egg allergy.

Authors:  Jean-Christoph Caubet; Julie Wang
Journal:  Pediatr Clin North Am       Date:  2011-04       Impact factor: 3.278

Review 6.  Does influenza vaccination exacerbate asthma?

Authors:  C L Park; A Frank
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

7.  Acceptance and Adverse Effects of H1N1 Vaccinations Among a Cohort of National Guard Health Care Workers during the 2009 Hajj Season.

Authors:  Gasmelseed Y Ahmed; Hanan H Balkhy; Saleh Bafaqeer; Badr Al-Jasir; Abdulhakeem Althaqafi
Journal:  BMC Res Notes       Date:  2011-03-13

8.  Values for preventing influenza-related morbidity and vaccine adverse events in children.

Authors:  Lisa A Prosser; Carolyn Buxton Bridges; Timothy M Uyeki; Virginia H Rêgo; G Thomas Ray; Martin I Meltzer; Benjamin Schwartz; William W Thompson; Keiji Fukuda; Tracy A Lieu
Journal:  Health Qual Life Outcomes       Date:  2005-03-21       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.